Sialoglycans on human T cells attenuate death programs executed through the Fas pathway
Vanessa Affe, Qianmeng Lei, Tim S. Veth, Emmajay Sutherland, Hani Choksi, Fauzia Nurul Izzati, Qingyu Shi, Haissi Cui, Nicholas McIlvain Riley, Landon J. Edgar
This study shows that sialoglycans on human T cells reduce Fas receptor-mediated apoptosis but not other TNF receptor pathways.
Journal of Biological Chemistry · Dec 12, 2025Peer-reviewedImmunology